Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Expanded Recommendations for OBRONA

24 Jul 2024 07:00

RNS Number : 5304X
Plant Health Care PLC
24 July 2024
 

24 July 2024

 

Plant Health Care plc

 ("Plant Health Care" or the "Company")

 

Expanded Recommendations to Support Commercial Sales of OBRONA® Biochemical Fungicide for Use on Corn, Soybean, and Wheat

  

Plant Health Care® (AIM.PHC.L), a leading provider of peptides used by growers to improve crop production and quality within global agriculture markets, is pleased to announce the issuance of new recommendations for use of OBRONA® biochemical fungicide to provide farmers with another tool to control a wide range of diseases and improve crop yield and harvest quality in corn, soybean and wheat in key US states.

 

Highlights:

- The new Section 2(ee) recommendations cover the use of OBRONA to control diseases in the following crops:

· Control in corn of common rust, gray leaf spot, northern and southern corn leaf blight and tar spot,

· Control in soybean of downy mildew, frogeye leaf spot, sclerotinia stem rot, and white mold,

· Control in wheat of multiple rust species: black, leaf, stem, stripe, and yellow rust. 

- These diseases represent serious threats to agricultural production and can significantly reduce crop yields, harvest quality, and grower profitability if not properly managed. OBRONA provides growers with a novel mode of action and an environmentally friendly tool to control these diseases and support sustainable agriculture based on reduced reliance on established synthetic pesticides. 

 

Section 2(ee) of the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) allows users to apply pesticides under certain limited conditions that are not specified on the commercial label. The recommendations shown above have been written to address control of target pests not listed on the OBRONA label.

 

Compared to current biocontrol products, OBRONA provides highly consistent and convenient product performance to control a broad spectrum of fungal and bacterial plant diseases. In addition to providing growers with a favorable return on investment, OBRONA brings growers convenience as it is compatible with many commonly used fungicides, herbicides, and insecticides in tank-mix and sequential application programs. OBRONA has no special requirements for storing or handling, which allows greater flexibility within the distribution channel and ease of on-farm application.

  

Jeff Tweedy, CEO of Plant Health Care, said: ‟Wilbur-Ellis is aggressively launching OBRONA this summer across the mid-west for disease control in corn, soybean and wheat. Results from field testing of OBRONA are very promising and we are excited to continue working with Wilbur-Ellis to bring the benefits of OBRONA to a wide range of growers across the country for the 2024 season."

 

  

# # #

 

For further information, please contact: 

Plant Health Care plc Jeff Tweedy, CEO

 

Tel: +1 919 926 1600

 

 

Cavendish Capital Markets Limited - Nomad & Broker Neil McDonald / Pete Lynch

 

Tel: +44 (0) 131 220 9771

 

 

For further information about Wilbur-Ellis, please contact: Jeanne Forbis, jforbis@wilburellis.com

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, sugarcane, potatoes, rice, and wheat, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors, and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com

 

About the Wilbur-Ellis Companies 

Founded in 1921, the Wilbur-Ellis companies are leading marketers, distributors and manufacturers of agricultural products and animal nutrients. By developing strong relationships, making strategic market investments, and capitalizing on new opportunities, the Wilbur-Ellis companies have continued to grow the business with sales of over $3.5 billion. For more information, please visit www.wilburellis.com

Wilbur-Ellis Agriculture, with annual sales revenue of $2.5 billion, has over 150 retail locations throughout the U.S.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAQKNBKABKDQOB
Date   Source Headline
21st Aug 20247:00 amRNSCancellation - Plant Health Care plc
20th Aug 202410:59 amRNSForm 8.5 (EPT/NON-RI)
20th Aug 202410:17 amRNSScheme of Arrangement becomes Effective
20th Aug 20247:30 amRNSSuspension - Plant Health Care plc
16th Aug 202410:14 amRNSExercise of Options & Rule 2.9 Announcement
16th Aug 20249:13 amRNSForm 8.5 (EPT/NON-RI)
15th Aug 202412:44 pmRNSCourt sanction of the Scheme of Arrangement
7th Aug 20246:02 pmRNSForm 8.3 - Plant Health Care Plc
7th Aug 20242:01 pmRNSForm 8.3 - Plant Health Care plc
7th Aug 20249:08 amRNSForm 8.3 - Plant Health Care PLC
6th Aug 20243:08 pmRNSResult of Court Meeting and General Meeting
6th Aug 20241:54 pmRNSForm 8.3 - Plant Health Care plc
6th Aug 202412:45 pmRNSHolding(s) in Company
5th Aug 20242:01 pmRNSForm 8.3 - Plant Health Care plc
5th Aug 20241:39 pmRNSResults of Court Meeting and General Meeting
2nd Aug 20242:00 pmRNSForm 8.3 - Plant Health Care plc
2nd Aug 20248:25 amRNSForm 8.3 - Plant Health Care PLC
1st Aug 20249:33 amRNSForm 8.3 - Plant Health Care PLC
1st Aug 20249:03 amRNSForm 8.5 (EPT/NON-RI)
1st Aug 20248:46 amRNSForm 8.3 - PLANT HEALTH CARE PLC
31st Jul 202411:21 amRNSForm 8.3 - Plant Health Care Plc
29th Jul 20241:09 pmRNSHolding(s) in Company
29th Jul 20248:51 amRNSForm 8.3 - PLANT HEALTH CARE PLC
24th Jul 20247:00 amRNSExpanded Recommendations for OBRONA
23rd Jul 20249:20 amRNSForm 8.5 (EPT/NON-RI) - Plant Health Care PLC
22nd Jul 202411:17 amRNSForm 8.5 (EPT/NON-RI)
19th Jul 20242:36 pmRNSForm 8.5 (EPT/NON-RI)
19th Jul 20242:10 pmRNSForm 8.3 - Plant Health Care plc
18th Jul 20249:05 amRNSForm 8.5 (EPT/NON-RI)
17th Jul 20249:03 amRNSForm 8.5 (EPT/NON-RI) - Plant Health Care PLC
16th Jul 20242:48 pmRNSForm 8.3 - Plant Health Care plc
16th Jul 202410:01 amRNSForm 8.5 (EPT/NON-RI)
15th Jul 202411:25 amRNSForm 8.5 (EPT/NON-RI)
15th Jul 202410:58 amRNSForm 8.3 - Plant Health Care Plc
12th Jul 20241:36 pmRNSForm 8.3 - Plant Health Care PLC
11th Jul 20242:28 pmRNSForm 8.3 - Plant Health Care plc
10th Jul 20243:44 pmRNSForm 8.3 - Plant Health Care plc
10th Jul 20242:58 pmRNSPublication and posting of the Scheme Document
10th Jul 20242:03 pmRNSForm 8.3 - Plant Health Care plc
10th Jul 202410:36 amRNSForm 8 (OPD) - Plant Health Care
9th Jul 20241:57 pmRNSForm 8.3 - Plant Health Care plc
9th Jul 202410:19 amRNSForm 8.3 - Plant Health Care plc - Ospraie Ag
8th Jul 20242:00 pmRNSForm 8.3 - Plant Health Care plc
8th Jul 20241:56 pmRNSForm 8.3 - Plant Health Care Plc
4th Jul 20241:40 pmPRNForm 8.3 - Plant Health Care plc
4th Jul 202411:09 amRNSForm 8.3 - Plant Health Care PLC - Amendment
4th Jul 20248:34 amRNSForm 8.3 - Plant Health Care PLC
3rd Jul 20241:57 pmRNSForm 8.3 - Plant Health Care plc
3rd Jul 20249:26 amRNSForm 8.3 - Plant Health Care plc
3rd Jul 20249:07 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.